Profile
Leah Makley was the founder of Viewpoint Therapeutics, Inc., founded in 2014, and held the title of Chief Executive Officer.
Dr. Makley currently holds the positions of Chief Operations Officer at MBC Biolabs and Chief Operating Officer at Deciduous Therapeutics, Inc. since 2022.
Dr. Makley completed an undergraduate degree at the University of Dayton in 2009 and a doctorate at the University of Michigan in 2014.
Leah Makley active positions
| Companies | Position | Start |
|---|---|---|
Deciduous Therapeutics, Inc.
Deciduous Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for immune mechanism | Chief Operating Officer | 2022-01-31 |
MBC Biolabs
MBC Biolabs Miscellaneous Commercial ServicesCommercial Services Provides life science research and development services | Chief Operating Officer | - |
Former positions of Leah Makley
| Companies | Position | End |
|---|---|---|
Viewpoint Therapeutics, Inc.
Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Develops non-surgical treatments for eye diseases | Chief Executive Officer | 2022-01-31 |
Training of Leah Makley
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
University of Dayton
University of Dayton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viewpoint Therapeutics, Inc.
Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Develops non-surgical treatments for eye diseases | Health Technology |
MBC Biolabs
MBC Biolabs Miscellaneous Commercial ServicesCommercial Services Provides life science research and development services | Commercial Services |
Deciduous Therapeutics, Inc.
Deciduous Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for immune mechanism | Health Technology |
- Stock Market
- Insiders
- Leah Makley
















